Annual EBIT
-$432.51M$43.68M+9.17%
Summary
- Current Value
- As of today, GH annual EBIT is -$432.51M, up +9.17% on
- Historical Performance
- GH annual EBIT is down -13.25% over the past 3 years, and down -531.01% over the past 5 years
- All-Time High Comparison
- GH annual EBIT is currently -903.15% below its historical high of -$43.12M set on
- 3-Year Low Comparison
- GH annual EBIT is +33.55% above its 3-year low of -$650.87M reached on an earlier date
- Sector Comparison
- GH annual EBIT is higher than 2.96% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$432.51M | +9.2% | -13.3% | -531.0% | -903.1% | |
| Quarterly EBIT | -$98.99M | +15.6% | +31.4% | -33.3% | -560.8% | |
| TTM EBIT | -$442.41M | +14.1% | +10.3% | -145.7% | -2853.3% | |
| Price | $110.17 | +201.1% | +296.4% | -22.9% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $739.02M | +31.0% | +97.8% | +244.7% | +2826.9% | |
| Annual EPS | -$3.56 | +17.0% | +11.2% | -325.8% | -558.2% | |
| Annual EBITDA | -$390.12M | +10.0% | -8.5% | -582.9% | -889.6% | |
| Annual Net Income | -$436.37M | +9.0% | -13.4% | -543.1% | -845.8% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$432.51M | at high | |
| 5Y | -$241.14M | N/A | -79.4% |
| All | -$43.12M | -903.1% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$650.87M | N/A | +33.5% |
| 5Y | -$650.87M | +33.5% | |
| All | -$650.87M | +33.5% |
EBIT History
| Year | Value | Change |
|---|---|---|
| -$432.51M | +9.2% | |
| -$476.19M | +26.8% | |
| -$650.87M | -70.4% | |
| -$381.89M | -58.4% | |
| -$241.14M | -251.8% |
| Year | Value | Change |
|---|---|---|
| -$68.54M | +17.4% | |
| -$82.97M | -3.1% | |
| -$80.51M | -86.7% | |
| -$43.12M | - |
FAQ
What is the current annual EBIT of GH?
As of today, GH annual EBIT is -$432.51M
What is 1-year change in GH annual EBIT?
GH annual EBIT is up +9.17% year-over-year
What is 3-year change in GH annual EBIT?
GH annual EBIT is down -13.25% over the past 3 years
How far is GH annual EBIT from its all-time high?
GH annual EBIT is currently -903.15% below its historical high of -$43.12M set on December 31, 2016
How does GH annual EBIT rank versus sector peers?
GH annual EBIT is higher than 2.96% of companies in Healthcare sector
When is GH next annual earnings release?
The next annual earnings release for GH is on
Quarterly EBIT
-$98.99M$7.42M+6.98%
Summary
- Current Value
- As of today, GH quarterly EBIT is -$98.99M, up +6.98% on
- Historical Performance
- GH quarterly EBIT is up +15.63% year-over-year, and up +31.35% over the past 3 years
- All-Time High Comparison
- GH quarterly EBIT is currently -560.81% below its historical high of -$14.98M set on
- 3-Year Low Comparison
- GH quarterly EBIT is +49.80% above its 3-year low of -$197.18M reached on
- Sector Comparison
- GH quarterly EBIT is higher than 3.39% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | -$98.99M | +7.0% | +15.6% | +31.4% | -33.3% | |
| Annual EBIT | -$432.51M | – | +9.2% | -13.3% | -531.0% | |
| TTM EBIT | -$442.41M | +4.0% | +14.1% | +10.3% | -145.7% | |
| Price | $110.17 | +68.8% | +201.1% | +296.4% | -22.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $265.20M | +14.3% | +38.5% | +125.9% | +255.6% | |
| Quarterly EPS | -$0.74 | +7.7% | +15.2% | +53.1% | +4.8% | |
| Quarterly EBITDA | -$89.59M | +7.1% | +16.1% | +33.3% | -28.2% | |
| Quarterly Net Income | -$92.73M | +7.2% | +13.9% | +42.8% | -29.4% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$98.99M | at high | |
| 3Y | -$98.99M | at high | |
| 5Y | -$91.17M | N/A | -8.6% |
| All | -$14.98M | -560.8% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$125.97M | N/A | +21.4% |
| 3Y | -$197.18M | +49.8% | |
| 5Y | -$197.18M | +49.8% | |
| All | -$197.18M | +49.8% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of GH?
As of today, GH quarterly EBIT is -$98.99M
What is GH quarterly EBIT most recent change?
GH quarterly EBIT was up +6.98% on September 30, 2025
What is 1-year change in GH quarterly EBIT?
GH quarterly EBIT is up +15.63% year-over-year
How far is GH quarterly EBIT from its all-time high?
GH quarterly EBIT is currently -560.81% below its historical high of -$14.98M set on March 1, 2017
How does GH quarterly EBIT rank versus sector peers?
GH quarterly EBIT is higher than 3.39% of companies in Healthcare sector
When is GH next earnings release?
The next earnings release for GH is on
TTM EBIT
-$442.41M$18.34M+3.98%
Summary
- Current Value
- As of today, GH TTM EBIT is -$442.41M, up +3.98% on
- Historical Performance
- GH TTM EBIT is up +14.06% year-over-year, and up +10.30% over the past 3 years
- All-Time High Comparison
- GH TTM EBIT is currently -2853.32% below its historical high of -$14.98M set on
- 3-Year Low Comparison
- GH TTM EBIT is +21.39% above its 3-year low of -$562.80M reached on
- Sector Comparison
- GH TTM EBIT is higher than 2.59% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | -$442.41M | +4.0% | +14.1% | +10.3% | -145.7% | |
| Annual EBIT | -$432.51M | – | +9.2% | -13.3% | -531.0% | |
| Quarterly EBIT | -$98.99M | +7.0% | +15.6% | +31.4% | -33.3% | |
| Price | $110.17 | +68.8% | +201.1% | +296.4% | -22.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $902.57M | +8.9% | +30.4% | +109.5% | +232.7% | |
| TTM EPS | -$3.21 | +4.0% | +24.2% | +45.9% | -68.1% | |
| TTM EBITDA | -$402.32M | +4.1% | +14.8% | +12.8% | -152.2% | |
| TTM Net Income | -$398.79M | +3.6% | +22.2% | +32.1% | -127.4% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$442.41M | at high | |
| 3Y | -$442.41M | at high | |
| 5Y | -$245.25M | N/A | -80.4% |
| All | -$14.98M | -2853.3% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$460.75M | +4.0% | |
| 3Y | -$562.80M | +21.4% | |
| 5Y | -$562.80M | +21.4% | |
| All | -$562.80M | +21.4% |
TTM EBIT History
FAQ
What is the current TTM EBIT of GH?
As of today, GH TTM EBIT is -$442.41M
What is GH TTM EBIT most recent change?
GH TTM EBIT was up +3.98% on September 30, 2025
What is 1-year change in GH TTM EBIT?
GH TTM EBIT is up +14.06% year-over-year
How far is GH TTM EBIT from its all-time high?
GH TTM EBIT is currently -2853.32% below its historical high of -$14.98M set on March 1, 2017
How does GH TTM EBIT rank versus sector peers?
GH TTM EBIT is higher than 2.59% of companies in Healthcare sector
When is GH next earnings release?
The next earnings release for GH is on
EBIT Formula
EBIT = Revenue − −
Data Sources & References
- GH Official Website guardanthealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1576280/000157628025000277/0001576280-25-000277-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1576280/000157628025000044/0001576280-25-000044-index.htm
- GH Profile on Yahoo Finance finance.yahoo.com/quote/GH
- GH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gh